GRAB vs AXSM Comparison

Founded in 2012, Grab provides ride-hailing services, food and grocery delivery, and financial services (payments, consumer loans, and enterprise offerings) in eight Southeast Asian countries through its mobile platform. The company partners with merchants and riders, connecting them with consumers while charging a commission to both sides. Grab has a leading market share and derives over 70% of its revenue from its core businesses, ride-hailing and food delivery. Singapore, Indonesia, and Malaysia contributed more than 70% of revenue in 2025. Grab's main competitors in Southeast Asia are Line Man and Goto. Its financial services business is still in its nascent stage and provides minimal revenue currently. The company now also generates advertising revenue.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.